Desferal

Active Ingredient(s): Deferoxamine
FDA Approved: * April 1, 1968
Pharm Company: * NOVARTIS
Category: Antidotes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Desferal Overview

Deferoxamine (DFOA), also known as desferrioxamine and sold under the brand name Desferal, is a medication that binds iron and aluminium.[1] It is specifically used in iron overdose, hemochromatosis either due to multiple blood transfusions or an underlying genetic condition, and aluminium toxicity in people on dialysis.[1][2] It is used by injection into a muscle, vein, or under the skin.[1] Common side effects include pain at t...

Read more Desferal Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Deferoxamine

Recent Desferal Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Deferoxamine
  • Injection: 2g, 2gm/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Desferal: (2 results)

Sorted by National Drug Code
  • 0078-0347 Desferal 2000 mg/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
  • 0078-0467 Desferal 500 mg/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation

Other drugs which contain Deferoxamine or a similar ingredient: (1 result)

Related Desferal Topics: